Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Cost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Insight Molecular Diagnostics (IMDX) Shares Outstanding (2016 - 2026)

Insight Molecular Diagnostics' Shares Outstanding history spans 7 years, with the latest figure at $28.7 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding rose 64.34% to $28.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $28.7 million, a 64.34% increase, with the full-year FY2025 number at $28.7 million, up 64.34% from a year prior.
  • Shares Outstanding hit $28.7 million in Q4 2025 for Insight Molecular Diagnostics, roughly flat from $28.6 million in the prior quarter.
  • Over the last five years, Shares Outstanding for IMDX hit a ceiling of $92.2 million in Q3 2021 and a floor of $5000.0 in Q2 2023.
  • Historically, Shares Outstanding has averaged $23.0 million across 5 years, with a median of $10.8 million in 2023.
  • Biggest five-year swings in Shares Outstanding: plummeted 99.99% in 2022 and later soared 571880.0% in 2025.
  • Tracing IMDX's Shares Outstanding over 5 years: stood at $4.6 million in 2021, then tumbled by 99.87% to $6000.0 in 2022, then decreased by 16.67% to $5000.0 in 2023, then surged by 348960.0% to $17.5 million in 2024, then soared by 64.34% to $28.7 million in 2025.
  • Business Quant data shows Shares Outstanding for IMDX at $28.7 million in Q4 2025, $28.6 million in Q3 2025, and $28.6 million in Q2 2025.